Filing Details

Accession Number:
0001209191-10-015806
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-09 12:00:00
Reporting Period:
2010-03-05
Filing Date:
2010-03-09
Accepted Time:
2010-03-09 20:40:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1303832 Allan Howard Simon 3280 Bayshore Boulevard
Brisbane CA 94005
Svp-Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-05 15,000 $10.11 15,000 No 4 M Direct
Common Stock Disposition 2010-03-05 15,000 $24.06 0 No 4 S Direct
Common Stock Acquisiton 2010-03-05 21,875 $12.74 21,875 No 4 M Direct
Common Stock Disposition 2010-03-05 21,875 $24.06 0 No 4 S Direct
Common Stock Disposition 2010-03-05 5,090 $24.05 24,238 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Optiom (Right to buy) Disposition 2010-03-05 15,000 $0.00 15,000 $10.11
Common Stock Employee Stock Optiom (Right to buy) Disposition 2010-03-05 21,875 $0.00 21,875 $12.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2005-09-10 2014-09-10 No 4 M Direct
0 2006-06-24 2015-06-24 No 4 M Direct
Footnotes
  1. The sale of these shares were made pursuant to a written trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, which was previously disclosed by InterMune in reports on Forms 8-K filed on March 13, 2009, June 18, 2008 and September 7, 2007.